Yoshida A, Kobayashi K, Manya H, Taniguchi K, Kano H, Mizuno M, Inazu T, Mitsuhashi H, Takahashi S, Takeuchi M, Herrmann R, Straub V, Talim B, Voit T, Topaloglu H, Toda T, Endo T
Central Laboratories for Key Technology, Kirin Brewery Co., Ltd., Kanazawa-ku, 236-0004, Yokohama, Japan.
Dev Cell. 2001 Nov;1(5):717-24. doi: 10.1016/s1534-5807(01)00070-3.
Muscle-eye-brain disease (MEB) is an autosomal recessive disorder characterized by congenital muscular dystrophy, ocular abnormalities, and lissencephaly. Mammalian O-mannosyl glycosylation is a rare type of protein modification that is observed in a limited number of glycoproteins of brain, nerve, and skeletal muscle. Here we isolated a human cDNA for protein O-mannose beta-1,2-N-acetylglucosaminyltransferase (POMGnT1), which participates in O-mannosyl glycan synthesis. We also identified six independent mutations of the POMGnT1 gene in six patients with MEB. Expression of most frequent mutation revealed a great loss of the enzymatic activity. These findings suggest that interference in O-mannosyl glycosylation is a new pathomechanism for muscular dystrophy as well as neuronal migration disorder.
肌肉-眼-脑疾病(MEB)是一种常染色体隐性疾病,其特征为先天性肌营养不良、眼部异常和无脑回畸形。哺乳动物O-甘露糖基糖基化是一种罕见的蛋白质修饰类型,仅在脑、神经和骨骼肌的有限数量糖蛋白中观察到。在此,我们分离出一种人类蛋白质O-甘露糖β-1,2-N-乙酰葡糖胺基转移酶(POMGnT1)的cDNA,该酶参与O-甘露糖聚糖合成。我们还在6例MEB患者中鉴定出POMGnT1基因的6个独立突变。最常见突变的表达显示酶活性大幅丧失。这些发现表明,O-甘露糖基糖基化的干扰是肌营养不良以及神经元迁移障碍的一种新的发病机制。